A detailed history of Suvretta Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 8,031,845 shares of ETNB stock, worth $65.7 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
8,031,845
Previous 6,298,004 27.53%
Holding current value
$65.7 Million
Previous $73.3 Million 12.24%
% of portfolio
2.69%
Previous 3.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.31 - $10.9 $12.7 Million - $18.9 Million
1,733,841 Added 27.53%
8,031,845 $64.3 Million
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $11.5 Million - $19.4 Million
1,409,570 Added 28.83%
6,298,004 $73.3 Million
Q4 2023

Feb 14, 2024

BUY
$6.66 - $16.03 $14.6 Million - $35.2 Million
2,194,030 Added 81.43%
4,888,434 $54.6 Million
Q3 2023

Nov 14, 2023

BUY
$15.06 - $19.41 $4.54 Million - $5.85 Million
301,168 Added 12.58%
2,694,404 $41.6 Million
Q2 2023

Aug 14, 2023

BUY
$14.15 - $22.03 $2.59 Million - $4.02 Million
182,700 Added 8.26%
2,393,236 $45.4 Million
Q1 2023

May 15, 2023

BUY
$10.48 - $16.94 $23.2 Million - $37.4 Million
2,210,536 New
2,210,536 $33.7 Million

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $380M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.